Johnson & Johnson

Pfizer, Merck, Johnson & Johnson to lose billions to Trump’s latest executive order Miami Herald10:05
Why is Johnson & Johnson (JNJ) down 4.9% Since last earnings report? Zacks12:37
Louisiana Jury returns $3M Plaintiff verdict in talc trial JD Supra14:26
Is the Trump administration about to cause AbbVie, Eli Lilly, and Johnson & Johnson stocks to crash? The Motley Fool04:58
Icotrokinra results show significant skin clearance in patients with difficult-to-treat scalp… PR Newswire (Press Release)08:08
Acto appoints former J&J president to its board of directors PR Newswire (Press Release)08:32
J&j renews bid to remove Beasley Allen from talc leadership Law.com16:38

Latest News

In the last 8 hours

BREAKING: J&J Unit Hit With $147M Verdict In Catheter Antitrust Suit Law36022:05 16-May-25

Yesterday

Here's Why Johnson & Johnson (JNJ) is a Strong Value Stock Zacks10:53 16-May-25

In the last 7 days

SMC approves Johnson & Johnson’s bladder cancer therapy Pharmaceutical Field17:56 15-May-25

Nachawati Law Group Files New Ovarian Cancer Lawsuits Against Johnson & Johnson After Latest… Business Wire (Press Release)17:56 15-May-25

Johnson & Johnson: Daniel’s road from refugee camp to Riderville … Micah’s second line of work Saskatchewan Roughriders (Official)17:22 15-May-25

If You Invested $25,000 In Johnson & Johnson (JNJ) 20 Years Ago, This Is How Much Cash From… 24/7 Wall St.15:36 15-May-25

Why Is Johnson & Johnson (JNJ) Down 4.9% Since Last Earnings Report? Zacks12:37 15-May-25

J&J Unit's Catheter Policy Stopped Free-Riding, Jury Told Law36022:55 14-May-25

Johnson & Johnson to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference Business Wire (Press Release)16:41 14-May-25

Icotrokinra Demonstrates Significant Skin Clearance in Difficult-to-Treat Scalp, Genital Psoriasis Pharmacy Times12:16 14-May-25

Critical Mass With Law.com's Amanda Bronstad: Why Aren't There Any Cases for the Mdl Panel to Hear This Month? Johnson… Law.com12:03 14-May-25

Johnson & Johnson’s bladder cancer therapy Balversa accepted by SMC PMLiVE07:43 14-May-25

Stylus Medicine launches with $85m to advance in vivo gene editing Pharmaceutical Technology07:01 14-May-25

Magistrate Judge Cuts Defendants In J&J Talc Unit Fraud Suit Law36021:49 13-May-25

Johnson & Johnson: For Those Who Want Some Immunity Against Tariff Changes Seeking Alpha17:44 13-May-25

Former J&J, Moderna Exec Joins Goodwin Procter In Boston Law36016:54 13-May-25

Noteworthy Tuesday Option Activity: NATL, ABNB, JNJ Nasdaq15:54 13-May-25

XLV, JNJ, ABBV, DHR: ETF Inflow Alert Nasdaq11:50 13-May-25

New Breast Implant Closes the Reconstruction Gapfor 1 in 7 Women After Breast Cancer Surgery Johnson & Johnson (Press Release)08:07 13-May-25

Stylus Medicine Launches to Develop Precision, In Vivo Genetic Medicines and Unlock the Full… Business Wire (Press Release)07:04 13-May-25

Small cap wrap: TNR Gold, BioHarvest, Arizona Gold & Silver, Zynex... Proactive Investors (US)15:33 12-May-25

Louisiana Jury Returns $3M Plaintiff Verdict in Talc Trial JD Supra14:26 12-May-25

European Commission approves Johnson & Johnson’s Crohn’s disease therapy Pharmafile10:41 12-May-25

Pfizer, Merck, Johnson & Johnson to lose billions to Trump’s latest executive order Miami Herald10:05 12-May-25

J&J/Protagonist’s icotrokinra shows promise in difficult-to-treat plaque psoriasis PMLiVE07:27 12-May-25

J&J reports new data from Phase III trial of icotrokinra for plaque psoriasis Clinical Trials Arena06:20 12-May-25

Tryptamine names global pharmaceutical leader as chairman Stockhead01:16 12-May-25

Tryptamine Therapeutics' new chairman to lead next phase of clinical growth Proactive Investors (Australia)22:23 11-May-25

In the last month

Wells Fargo, J&J Workers Tap COBRA Recipients to Save Cost Suits Bloomberg Law13:29 9-May-25

Protagonist/Johnson & Johnson Partnered Drug Shows Significant Skin Clearance In Pivotal Psoriasis Study Benzinga12:22 9-May-25

J&J MedTech partners with Qure.ai to boost early lung cancer detection in India The Hindu Business Line12:20 9-May-25

Johnson & Johnson Stock (JNJ) Fails to Clean Up Despite Success in Near $1B Psoriasis Pill Trial TipRanks12:05 9-May-25

Icotrokinra results show significant skin clearance in patients with difficult-to-treat scalp… PR Newswire (Press Release)08:08 9-May-25

J&J Unit's Encryption Tech Stalled Rival, Antitrust Jury Told Law36000:18 9-May-25

Jury Orders Johnson & Johnson to Pay $3 Million in Mesothelioma Death of New Orleans Woman Business Wire (Press Release)12:10 8-May-25

Majority of Europeans trust technology to improve healthcare, Johnson & Johnson survey finds Pharmafile09:17 8-May-25

Acto Appoints Former J&J President To Its Board Of Directors PR Newswire (Press Release)08:32 8-May-25

Johnson & Johnson expands efforts to champion the nursing workforce globally Business Wire (Press Release)08:20 8-May-25

J&J Medtech survey finds strong European support for healthcare data sharing Verdict Medical Devices04:32 8-May-25

J&J Unit's Catheter Tying Policy Hurt Rival, Antitrust Jury Told Law36000:45 8-May-25

Investors Fight J&J, Kenvue Bid To Nix IPO Fraud Suit Law36023:13 7-May-25

J&J Renews Bid to Remove Beasley Allen From Talc Leadership Law.com16:38 7-May-25

The Zacks Analyst Blog Highlights Johnson & Johnson and AbbVie Barchart09:57 7-May-25

Johnson & Johnson shares long-term results for Tremfya in ulcerative colitis PMLiVE07:35 7-May-25

Medtech Leaders Speak Out On Impact of Global Tariffs JD Supra13:52 6-May-25

The Zacks Analyst Blog Highlights GE Healthcare, Johnson & Johnson, Abbott and Boston Scientific Zacks10:15 6-May-25

Here is What to Know Beyond Why Johnson & Johnson (JNJ) is a Trending Stock Zacks10:05 6-May-25

Do Wall Street Analysts Like Johnson & Johnson Stock? Barchart08:00 6-May-25

Meet two Johnson & Johnson nurse educators dedicated to teaching cancer care providers Johnson & Johnson (Press Release)07:45 6-May-25

Johnson & Johnson submits application for subcutaneous Rybrevan dosing PharmaTimes06:01 6-May-25

‘A call to conscience’: Former Cji Chandrachud at launch of The Indian Express journalist’s book Indian Express18:34 5-May-25

District of New Jersey Denies Preliminary Injunction in Ustekinumab Breach of Contract Case JD Supra12:41 5-May-25

New J&J data signals progress in ulcerative colitis treatment landscape European Pharmaceutical Review11:33 5-May-25

Johnson & Johnson’s New “Oncology Care Index” Highlights the Growing Divide Between Cancer Innovation and… Johnson & Johnson (Press Release)09:01 5-May-25

TREMFYA® (guselkumab) delivers sustained clinical and endoscopic remission in ulcerative colitis through two years Johnson & Johnson (Press Release)08:10 5-May-25

TREMFYA® (guselkumab) positioned to become the first and only IL-23 inhibitor to offer subcutaneous induction in… Johnson & Johnson (Press Release)08:10 5-May-25

After striking out in bankruptcy court, Johnson & Johnson goes after expert witness in talc… FiercePharma08:07 5-May-25

Is the Trump Administration About to Cause AbbVie, Eli Lilly, and Johnson & Johnson Stocks to Crash? The Motley Fool04:58 4-May-25

‘Rooted in Falsehood': J&J Moves to Reopen Suit Against Leading Talc Expert Law.com21:02 2-May-25

Johnson & Johnson (NYSE:JNJ) Is Increasing Its Dividend To $1.30 Simply Wall St19:49 2-May-25

Johnson & Johnson Stock (JNJ) Perks Up as it Mulls $2.5B Purchase of Sonic Beam Cancer Fighting … TipRanks12:50 2-May-25

Johnson & Johnson’s Imaavy granted FDA approval for rare autoimmune disease gMG PMLiVE07:15 2-May-25

Couple's J&J Pelvic Mesh Claims Too Late, 11th Circ. Affirms Law36019:49 1-May-25

J&J Talc Unit Says New Doc 'Key' To Talc Study Libel Suit Law36017:58 1-May-25

FDA approves J&J’s Imaavy for generalised myasthenia gravis Pharmaceutical Technology06:36 1-May-25

The Zacks Analyst Blog Highlights Amazon, Johnson & Johnson, Cisco Systems and NeurAxis Zacks05:51 1-May-25

J&J's 'Swiss army knife' drug gets first FDA approval pharmaphorum05:05 1-May-25

Top Stock Reports for Amazon.com, Johnson & Johnson & Cisco Systems Zacks18:11 30-Apr-25

Johnson & Johnson Shareholders Approve 2025 Director Nominees TipRanks17:14 30-Apr-25

J&J secures FDA OK for immune drug touted as future blockbuster BioPharma Dive12:35 30-Apr-25

FDA Approves Nipocalimab for Adult and Pediatric Myasthenia Gravis Medpage Today12:32 30-Apr-25

Francis Johnson on overcoming challenges in the E&S Market Insurance Business Magazine US10:28 30-Apr-25

FDA Approves Nipocalimab for Generalized Myasthenia Gravis American Journal of Managed Care10:18 30-Apr-25

FDA approves Johnson & Johnson's rare disease drug that's expected to compete with argenx and UCB ENDPOINTS09:29 30-Apr-25

US FDA approves Johnson & Johnson's drug for immune-mediated disorder Mint09:03 30-Apr-25

Johnson & Johnson receives FDA approval for IMAAVYTM (nipocalimab-aahu), a new FcRn blocker offering long-lasting… Johnson & Johnson (Press Release)08:33 30-Apr-25

J&J Unit Moves to Renew Libel Suit Against Cancer Study Author Bloomberg Law17:35 29-Apr-25

J&J Loses Bid to Block Samsung Bioepis Second Stelara Biosimilar Bloomberg Law10:58 29-Apr-25

AACR 2025: Expert to share promising results on new immunotherapy approach in non-small cell… ecancer07:59 29-Apr-25

Nvidia, Johnson & Johnson, Hyundai, Toyota, SoftBank CEOs To Join Trump At White House As He Touts Investment Surge In… Benzinga05:35 29-Apr-25

EU Approves Tremfya In Third Indication, Ulcerative Colitis Scrip Pharma Intelligence05:22 29-Apr-25

Trump to tout US investments from Nvidia, J&J, Hyundai, Toyota Yahoo! US19:19 28-Apr-25

Johnson & Johnson to Participate in the Bernstein’s 41st Annual Strategic Decisions Conference Business Wire (Press Release)16:26 28-Apr-25

Plaintiff Sues Eli Lilly, Johnson & Johnson Over Alleged Breast Cancer Risk Linked To Antipsychotic Medications Benzinga16:13 28-Apr-25

New data from J&J’s bladder cancer drug-device trial strengthens support for NDA Verdict Medical Devices13:05 28-Apr-25

J&J’s Tremfya gains EC marketing authorisation for ulcerative colitis Pharmaceutical Technology12:50 28-Apr-25

Kristine Sulakadze: Driving Process Innovation at Johnson & Johnson’s European Hub Georgia Today02:26 28-Apr-25

Surgeon in battle with Johnson & Johnson over spine tech: Briton and colleague 'not paid' for work This is Money16:56 26-Apr-25

Johnson & Johnson's TAR-200 monotherapy achieves high disease-free survival of more than 80… PR Newswire (Press Release)14:02 26-Apr-25

Johnson & Johnson's TAR-200 monotherapy demonstrates highest complete response rate with… PR Newswire (Press Release)13:52 26-Apr-25

These 2 Top Dividend Stocks Are Making Moves to Avoid the Impact of Tariffs: Are They Buys? The Motley Fool10:23 26-Apr-25

J&J Unit Sees Claims Trimmed In Engineer's Bias Suit Law36016:52 25-Apr-25

Johnson & Johnson MedTech Presents 3-Month Data from Omny-IRE Clinical Trial at 2025 Heart… PR Newswire (Press Release)16:37 25-Apr-25

Roswell Park Expert to Share Promising Results on New Immunotherapy Approach in Non-Small Cell Lung Cancer Newswise (Press Release)15:30 25-Apr-25

Dividend Kings Face-Off: Johnson & Johnson (JNJ) Vs. Procter & Gamble (PG) 24/7 Wall St.14:25 25-Apr-25

Johnson & Johnson to Present New Data for TECNIS Odyssey, The Fastest Growing PCIOL in the… PR Newswire (Press Release)08:08 25-Apr-25

Johnson & Johnson’s Tremfya granted EC approval to treat ulcerative colitis in adults PMLiVE07:26 25-Apr-25

Book review: Gardiner Harris’ new exposé competently uncovers Johnson & Johnson ethical battles Daily Bruin01:13 25-Apr-25

Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know Zacks10:08 24-Apr-25

11th Circ. Considers Timeliness Of J&J Pelvic Mesh Claims Law36023:00 23-Apr-25

J&J and Eli Lilly Concealed Breast Cancer Risks in Blockbuster Antipsychotics for Decades,… PR Newswire (Press Release)16:14 23-Apr-25

Dividend Kings Down Today: Why Johnson & Johnson (JNJ), Coca-Cola (KO) and Procter & Gamble… 24/7 Wall St.11:12 23-Apr-25

Ganga Hospital, Coimbatore, designated as global centre of excellence in trauma, joint replacement, arthroscopy… The Hindu10:49 23-Apr-25

Why Johnson & Johnson (JNJ) is a Top Value Stock for the Long-Term Zacks10:44 23-Apr-25

J&J Ends Trade Secrets Suit Against Now Deceased Ex-Exec Law36017:48 22-Apr-25

Johnson & Johnson (NYSE:JNJ) Showcases Paradigm-Shifting Bladder Cancer Trials at AUA 2025 Simply Wall St16:23 22-Apr-25

Stock Watch: Dollar Weakness, Tariffs, Biosimilars In J&J’s Q1 Mix Scrip Pharma Intelligence12:40 22-Apr-25

Data readout puts J&J's bladder cancer drug back on track pharmaphorum06:50 22-Apr-25

Johnson & Johnson (JNJ): Buy, Sell, or Hold Post Q1 Earnings? Barchart06:02 22-Apr-25

J&J highlights Rybrevant-Leclaza combo’s survival benefit in EGFR-mutant lung cancer Korea Biomedical Review02:25 22-Apr-25

Johnson & Johnson unveils highly anticipated and potential practice-changing data in bladder cancer treatment at AUA Johnson & Johnson (Press Release)09:34 21-Apr-25

2 Recession-Proof Stocks to Buy With a Better Credit Rating Than the U.S. Government The Motley Fool07:36 20-Apr-25

Future Claims Rep for J&J Loses Bid to Revive Bankruptcy Plan Bloomberg Law12:49 18-Apr-25

Johnson & Johnson: 15% of AI Use Cases Deliver 80% of Value PYMNTS.com10:20 18-Apr-25

Johnson & Johnson (NYSE:JNJ) Is Paying Out A Larger Dividend Than Last Year Simply Wall St07:23 18-Apr-25

view more headlines

16 May 22:05

About our Johnson & Johnson news

Latest news on Johnson & Johnson, the American multinational pharmaceutical, known for developing healthcare, pharmaceuticals, and consumer products. Stay updated on stories about their pioneering medical advancements, including vaccines, treatments, and medical devices. Explore insights into the company’s financial performance, share prices, leadership changes, and global strategies.

Johnson & Johnson

Latest News

About our Johnson & Johnson news

Business Top Stories